MILANOVA TSVETA 1957180 Data last updated 2024-05-11 06:58:14 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | 2023-06-28 | 2023-06-28 | 4 | Milanova Tsveta | CHIEF COMMERCIAL OFFICER | acq | 5449.0 | 100.0 | 0.98 | 0.0 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code M | 5449.0 | 55.58 (AGIO) |
| 2023-06-30 | 2023-06-28 | 2023-06-30 | 4 | Milanova Tsveta | CHIEF COMMERCIAL OFFICER | dsp | 1618.0 | 29.69 | 0.29 | 28.36 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code S | 3831.0 | 55.58 (AGIO) |
| 2024-01-05 | 2024-01-03 | 2024-01-03 | 4 | Milanova Tsveta | CHIEF COMMERCIAL OFFICER | acq | 8475.0 | 68.87 | 1.52 | 0.0 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code M | 12306.0 | 55.89 (AGIO) |
| 2024-01-05 | 2024-01-03 | 2024-01-05 | 4 | Milanova Tsveta | CHIEF COMMERCIAL OFFICER | dsp | 2902.0 | 23.58 | 0.52 | 22.32 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code S | 9404.0 | 55.89 (AGIO) |
| 2024-01-24 | 2024-01-20 | 2024-01-20 | 4 | Milanova Tsveta | CHIEF COMMERCIAL OFFICER | acq | 5448.0 | 36.68 | 0.97 | 0.0 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code M | 14852.0 | 55.89 (AGIO) |
| 2024-01-24 | 2024-01-20 | 2024-01-24 | 4 | Milanova Tsveta | CHIEF COMMERCIAL OFFICER | dsp | 1618.0 | 10.89 | 0.29 | 21.64 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code S | 13234.0 | 55.89 (AGIO) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | 2023-06-28 | 2023-06-28 | 4 | Milanova Tsveta | CHIEF COMMERCIAL OFFICER | dsp | 5449.0 | 50.0 | 0.98 | 0.0 | Direct | Performance Share Units | AGIOS PHARMACEUTICALS, INC. | code M | 5448.0 | 55.58 (AGIO) |
| 2024-01-05 | 2024-01-03 | 2024-01-03 | 4 | Milanova Tsveta | CHIEF COMMERCIAL OFFICER | dsp | 8475.0 | 33.33 | 1.52 | 0.0 | Direct | Restricted Stock Units | AGIOS PHARMACEUTICALS, INC. | code M | 16951.0 | 55.89 (AGIO) |
| 2024-01-24 | 2024-01-20 | 2024-01-20 | 4 | Milanova Tsveta | CHIEF COMMERCIAL OFFICER | dsp | 5448.0 | 100.0 | 0.97 | 0.0 | Direct | Performance Share Units | AGIOS PHARMACEUTICALS, INC. | code M | 0.0 | 55.89 (AGIO) |
| 2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Milanova Tsveta | CHIEF COMMERCIAL OFFICER | acq | 17000.0 | 100.0 | 3.03 | 0.0 | Direct | Restricted Stock Units | AGIOS PHARMACEUTICALS, INC. | code A | 17000.0 | 56.19 (AGIO) |
| 2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Milanova Tsveta | CHIEF COMMERCIAL OFFICER | acq | 60000.0 | 100.0 | 10.68 | 32.27 | Direct | Stock Options (Right To Buy) | AGIOS PHARMACEUTICALS, INC. | code A | 60000.0 | 56.19 (AGIO) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)